NO942472L - Okulært hypotensivt middel - Google Patents

Okulært hypotensivt middel

Info

Publication number
NO942472L
NO942472L NO942472A NO942472A NO942472L NO 942472 L NO942472 L NO 942472L NO 942472 A NO942472 A NO 942472A NO 942472 A NO942472 A NO 942472A NO 942472 L NO942472 L NO 942472L
Authority
NO
Norway
Prior art keywords
hypotensive agent
ocular hypotensive
hydrocarbon residue
represents hydrogen
group capable
Prior art date
Application number
NO942472A
Other languages
English (en)
Other versions
NO942472D0 (no
Inventor
Takahiro Ogawa
Takaaki Deguchi
Keijii Kubo
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO942472D0 publication Critical patent/NO942472D0/no
Publication of NO942472L publication Critical patent/NO942472L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Det blir beskrevet et okulaert hypotensivt middel som omfatter en forbindelse representert ved formelen: hvor R1 står for hydrogen eller en eventuelt substitu- ert hydrokarbonrest som kan være bundet via et heteroatom; R2 står for hydrogen eller en hydrokarbon- rest som kan ha en substltuent; R^ står for en gruppe som er Istand til å danne et anion eller en gruppe som er Istand til å forandres til et slikt; X er en kovalent binding mellom de to benzenrlngene eller et avstandsstykke med kjedelengde på l til 2 atomer som den lineære del mellom de to sammenbundede fenylen og fenylgruppene; n står for l eller 2; ring A er en benzenring som har l eller 2 eventuelle substituenter i tillegg til gruppen representer ved COOR2, eller et farmasøytisk akseptabelt salt av dette.
NO942472A 1993-07-02 1994-06-30 Okulært hypotensivt middel NO942472L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16484793 1993-07-02

Publications (2)

Publication Number Publication Date
NO942472D0 NO942472D0 (no) 1994-06-30
NO942472L true NO942472L (no) 1995-01-03

Family

ID=15801055

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942472A NO942472L (no) 1993-07-02 1994-06-30 Okulært hypotensivt middel

Country Status (14)

Country Link
US (1) US5639773A (no)
EP (1) EP0631780A1 (no)
KR (1) KR950002760A (no)
CN (1) CN1105239A (no)
AU (2) AU7083394A (no)
BR (1) BR9402618A (no)
CA (1) CA2127202A1 (no)
CZ (1) CZ154994A3 (no)
FI (1) FI943182A (no)
HU (1) HUT69713A (no)
NO (1) NO942472L (no)
PL (1) PL304080A1 (no)
SK (1) SK78994A3 (no)
WO (1) WO1995001176A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1110551E (pt) * 1994-03-16 2004-07-30 Sankyo Co Redutor de tensao ocular
RU2239454C2 (ru) * 1999-04-28 2004-11-10 Такеда Кемикал Индастриз, Лтд. Фармацевтическая композиция для предотвращения, лечения или ингибирования развития простой ретинопатии и препролиферирующей ретинопатии
WO2000076543A1 (fr) * 1999-06-11 2000-12-21 Sankyo Company, Limited Composition permettant de reduire la tension oculaire et destinee a l'administration topique
EP1197226B1 (en) * 1999-07-21 2007-11-21 Takeda Pharmaceutical Company Limited Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
TWI290470B (en) * 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
US7232828B2 (en) 2002-08-10 2007-06-19 Bethesda Pharmaceuticals, Inc. PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
PT1872783E (pt) * 2005-04-21 2012-01-16 Santen Pharmaceutical Co Ltd Agente terapêutico para distúrbio queratoconjuntivo
CN101677961B (zh) * 2007-03-28 2012-10-17 武田药品工业株式会社 包含苯并咪唑-7-羧酸酯衍生物和pH控制剂的固体药物组合物
ES2616238T3 (es) 2010-10-06 2017-06-12 Glaxosmithkline Llc, Corporation Service Company Derivados de bencimidazol como inhibidores de PI3 quinasa

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
DE69013607T2 (de) * 1989-08-02 1995-03-02 Takeda Chemical Industries Ltd Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
EP0434038A1 (en) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
DE69129998T2 (de) * 1990-02-15 1998-12-24 Takeda Chemical Industries Ltd Pyrimidindionderivate, deren Herstellung und Verwendung
US5284661A (en) * 1990-02-22 1994-02-08 Takeda Chemical Industries, Ltd. Fused thiophene derivatives, their production and use
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
EP0525129A4 (en) * 1990-04-13 1993-03-24 Smith-Kline Beecham Corporation Substituted benzimidazoles
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5102903A (en) * 1990-05-10 1992-04-07 E. I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with pyrazole, pyrrole and triazole angiotensin-II receptor antagonists
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
TW274551B (no) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
EP0829479B1 (en) * 1992-09-14 2004-04-14 Takeda Chemical Industries, Ltd. Heterocyclic compounds and their use as angiotensin II antagonists
ATE204276T1 (de) * 1992-12-22 2001-09-15 Takeda Chemical Industries Ltd Heterocyclische verbindungen mit angiotensin-ii- antagonistischer wirkung und ihre anwendung

Also Published As

Publication number Publication date
CZ154994A3 (en) 1995-09-13
HUT69713A (en) 1995-09-28
WO1995001176A1 (en) 1995-01-12
NO942472D0 (no) 1994-06-30
CA2127202A1 (en) 1995-01-03
US5639773A (en) 1997-06-17
CN1105239A (zh) 1995-07-19
EP0631780A1 (en) 1995-01-04
FI943182A0 (fi) 1994-07-01
SK78994A3 (en) 1995-07-11
KR950002760A (ko) 1995-02-16
FI943182A (fi) 1995-04-04
AU6614694A (en) 1995-01-12
HU9402006D0 (en) 1994-09-28
BR9402618A (pt) 1995-04-04
AU7083394A (en) 1995-01-24
PL304080A1 (en) 1995-01-09

Similar Documents

Publication Publication Date Title
BG108174A (en) 5-phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
EP1564213A4 (en) IMIDAZOLE DERIVATIVES, PROCESS FOR THE PRODUCTION AND USE THEREOF
HUP0302422A2 (hu) Hashajtó hatású kompozíció és alkalmazása gyógyszer előállítására
HUP0302960A2 (hu) Kemokinreceptorhoz kötődő heterociklusos vegyületek, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
YU48390B (sh) Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate
IL146309A0 (en) Indole-type derivatives as inhibitors of p38 kinase
MD1743B2 (ro) Derivaţi ai indolului, procedeu de obţinere a lor, compoziţie fungicidă şi procedeu de combatere a fungilor
NO942472L (no) Okulært hypotensivt middel
FR2358891A1 (fr) Composes heterocycliques contenant un azote, utilise comme agents analgesiques et anti-inflammatoires
DK1063228T3 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
MY110142A (en) Thiazolidinedione derivatives, their production and use
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
NO954072L (no) Vannopplöselige camptotecinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler
CA2178604A1 (en) Novel imidazole derivative and process for producing the same
ES2131301T3 (es) Derivado de isoxazolidindiona y su utilizacion.
MY106533A (en) A 4-tert.-butyl imidazole derivative and its production and use.
ES2029801T3 (es) Procedimiento para preparar acidos tetrahidro-3-piridina-carboxilicos sustituidos y esteres y amidas de los mismos con actividad colinergica.
RU1838323C (ru) Способ получени бензопиранон- @ -Д-тиоксилозидов
NO941832D0 (no) Benzopyranderivater og deres anvendelse
CA2266006A1 (en) Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
ATE196464T1 (de) Benzol-derivate, verwendbar für ischämische erkrankungen
ATE104939T1 (de) Dicyclohexylethylenderivate.
TW366264B (en) Herbicidal 3-substituted pyridine compounds and derivatives thereof
AU6594900A (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof andagents
ES2075191T3 (es) 1-(3-(2-hidroxi-3-alquilaminopropoxi)-2-tienil)-3-fenil-1-propanonas y procedimiento para su preparacion.